These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 752855)

  • 1. Active specific immunotherapy in ovarian cancer.
    Crowther ME; Levin L; Poulton TA; Saffrey MJ; Curling OM; Hudson CN
    Recent Results Cancer Res; 1978; 68():166-73. PubMed ID: 752855
    [No Abstract]   [Full Text] [Related]  

  • 2. Chemoimmunotherapy for advanced ovarian carcinoma with adriamycin-cyclophosphamide +/- BCG: early report of a Southwest Oncology Group study.
    Alberts DS; Salmon SE; Moon TE
    Recent Results Cancer Res; 1978; 68():160-5. PubMed ID: 752854
    [No Abstract]   [Full Text] [Related]  

  • 3. Current concepts in cancer: ovary--treatment for stages III and IV. Chemotherapy in advanced disease.
    Young RC; Myers CE; Ozols RF; Hogan WM
    Int J Radiat Oncol Biol Phys; 1982 May; 8(5):899-902. PubMed ID: 6809710
    [No Abstract]   [Full Text] [Related]  

  • 4. Randomized phase III trial of chemoimmunotherapy in patients with previously untreated stages III and IV suboptimal disease ovarian cancer: a Southwest Oncology Group Study.
    Alberts DS; Mason-Liddil N; O'Toole RV; Abbott TM; Kronmal R; Hilgers RD; Surwit EA; Eyre HJ; Baker LH
    Gynecol Oncol; 1989 Jan; 32(1):8-15. PubMed ID: 2642455
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Randomized phase III trial of chemoimmunotherapy in patients with previously untreated stage III, optimal disease ovarian cancer: a Southwest Oncology Group Study.
    Alberts DS; Mason-Liddil N; O'Toole RV; Abbott TM; Kronmal R; Hilgers RD; Surwit EA; Eyre HJ; Baker LH
    Gynecol Oncol; 1989 Jan; 32(1):16-21. PubMed ID: 2642453
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A randomized trial of cyclophosphamide, doxorubicin, and cisplatin with or without bacillus Calmette-Guerin in patients with suboptimal stage III and IV ovarian cancer: a Gynecologic Oncology Group study.
    Creasman WT; Omura GA; Brady MF; Yordan E; DiSaia PJ; Beecham J
    Gynecol Oncol; 1990 Dec; 39(3):239-43. PubMed ID: 2258063
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Randomized study of chemoimmunotherapy for advanced ovarian carcinoma: a preliminary report of a Southwest Oncology Group study.
    Alberts DS; Moon TE; Stephens RA; Wilson H; Oishi N; Hilgers RD; O'Toole R; Thigpen JT
    Cancer Treat Rep; 1979 Feb; 63(2):325-31. PubMed ID: 376137
    [No Abstract]   [Full Text] [Related]  

  • 8. Cyclophosphamide, hexamethylmelamine, doxorubicin, and cisplatin (CHAD) as second-line chemotherapy for ovarian adenocarcinoma.
    Piver MS; Lele S; Barlow JJ
    Cancer Treat Rep; 1981; 65(1-2):149-51. PubMed ID: 6784921
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hexamethylmelamine-CAF (cyclophosphamide, methotrexate, and 5-FU) and cisplatin-CAF in refractory ovarian cancer.
    Sessa C; D'Incalci M; Valente I; Bolis G; Colombo N; Mangioni C
    Cancer Treat Rep; 1982 May; 66(5):1233-4. PubMed ID: 6805951
    [No Abstract]   [Full Text] [Related]  

  • 10. Treatment of chemotherapy-resistant advanced ovarian cancer with a combination of cyclophosphamide, hexamethylmelamine, adriamycin, and cis-diamminedichloroplatinum (CHAP).
    Bruckner HW; Cohen CJ; Deppe G; Kabakow B; Wallach R; Ratner L; Holland JF
    Gynecol Oncol; 1981 Oct; 12(2 Pt 1):150-3. PubMed ID: 6795095
    [No Abstract]   [Full Text] [Related]  

  • 11. Improved therapy with cisplatin regimens for patients with ovarian carcinoma (FIGO III and IV) as measured by surgical end-staging (second-look surgery)--the mount sinai experience.
    Cohen CJ; Bruckner HW; Goldberg JD; Holland JF
    Clin Obstet Gynaecol; 1983 Aug; 10(2):307-24. PubMed ID: 6413114
    [No Abstract]   [Full Text] [Related]  

  • 12. [Progress in the chemotherapy of ovarian cancer].
    Honetz N
    Wien Med Wochenschr; 1982 Jul; 132(13-14):319-24. PubMed ID: 6291259
    [No Abstract]   [Full Text] [Related]  

  • 13. Intensified nutrition as an adjunct to cytotoxic chemotherapy in gynaecological cancer patients.
    Nuutinen LS; Kauppila A; Ryhänen P; Niinimäki A; Kivinen S; Saarela M; Pakarinen A; Hollmén A
    Clin Oncol; 1982 Jun; 8(2):107-12. PubMed ID: 6809386
    [No Abstract]   [Full Text] [Related]  

  • 14. [Phase III study of cisplatin on gynecological malignancy].
    Chen JT; Takizawa K; Kawana T; Kawagoe K; Yoshida R; Yoshikawa H; Mizuno M; Sakamoto S
    Nihon Gan Chiryo Gakkai Shi; 1982 Apr; 17(3):710-9. PubMed ID: 6182259
    [No Abstract]   [Full Text] [Related]  

  • 15. [Chemotherapic management of genitomammary tumors].
    Sarría JA; Irigoyen ML; Cismondi B
    Rev Fac Cien Med Univ Nac Cordoba; 1981; 39(1-4):3-16. PubMed ID: 6897122
    [No Abstract]   [Full Text] [Related]  

  • 16. Chemotherapy for stage III-IV epithelial ovarian cancer with cis-dichlorodiammineplatinum(II), adriamycin, and cyclophosphamide: a preliminary report.
    Ehrlich CE; Einhorn L; Williams SD; Morgan J
    Cancer Treat Rep; 1979 Feb; 63(2):281-8. PubMed ID: 376134
    [No Abstract]   [Full Text] [Related]  

  • 17. [Effectiveness of 3-drug therapy in patients with advanced ovarian cancer].
    Kwaśniewska-Rokicińska C; Kaleta B; Kumor-Głodny T
    Ginekol Pol; 1989 Feb; 60(2):86-9. PubMed ID: 2680790
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adjuvant chemoimmunotherapy following regional therapy for isolated recurrences of breast cancer (stage IV NED).
    Buzdar AU; Blumenschein GR; Smith TL; Tashima CK; Hortobagyi GN; Yap HY; Gutterman JU; Hersh EM; Gehan EA
    J Surg Oncol; 1979; 12(1):27-40. PubMed ID: 480951
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alternating multiagent chemotherapy for advanced ovarian cancer.
    Hernandez E; Rosenshein NB; Villar J; Dillon MB; Ettinger DS; Order SE
    J Surg Oncol; 1983 Feb; 22(2):87-91. PubMed ID: 6296547
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of ovarian cancer with a combination of cis-platinum, adriamycin, cyclophosphamide and hexamethylmelamine.
    Razis DV; Poulakou E; Petounis A; Papadimitriou G; Kosmides P; Delides G
    Oncology; 1982; 39(4):205-8. PubMed ID: 6806735
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.